Role of Innate B1 B Cells in the Development of Diffuse Lung Hemorrhage
先天 B1 B 细胞在弥漫性肺出血发展中的作用
基本信息
- 批准号:9182833
- 负责人:
- 金额:$ 19.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute respiratory failureAdoptive TransferAffectAlkanesAnhydridesAnimal ModelAnimalsAntibodiesAntigensApoptoticAutoimmunityB-Cell ActivationB-LymphocytesBLR1 geneBioinformaticsBone Marrow TransplantationBreathingC57BL/6 MouseCXC ChemokinesCXCL13 geneCellsClinicalCommunitiesCosmeticsCrack CocaineDataDevelopmentDiesel ExhaustDiffuseDiseaseEventExposure toFoodFrequenciesGene Expression ProfilingGenesGleanGreater sac of peritoneumHemorrhageHeterogeneityHomeostasisHomingHouse DustHumanITGAM geneImmuneImmunoglobulin MIndividualInfectious AgentInfiltrationInflammationIngestionInjection of therapeutic agentIsocyanatesLifeLigandsLiverLocationLungLupusLymphoidMediatingMineral OilMolecularMusMyeloid CellsOilsOrganOrgan TransplantationPathogenesisPathway interactionsPatientsPeritonealPeritoneumPesticidesPetroleumPharmaceutical PreparationsPhenytoinPlantsPleuraPleuralPleural cavityPoisonPopulation ControlPrevalencePristanePropylthiouracilPublic HealthPulmonary InflammationRecreational DrugsRoleSeveritiesSiteSkinSkin AbsorptionSyndromeTestingTimeTissuesToxinTranslatingVasculitisWorkbasecell typechemokine receptorchemotherapeutic agenteffective therapyexposed human populationhexadecanein vivo Modellymph nodesmarine organismmortalitynovelpentadecaneperipheral bloodpotential biomarkersystemic autoimmune diseasetraffickingwasting
项目摘要
ABSTRACT
Diffuse lung hemorrhage is a distinct clinicopathologic syndrome of lung hemorrhage, inflammation, vasculitis,
and acute respiratory failure. It carries a very high mortality, and is without any effective treatment. Diffuse lung
hemorrhage can occur in patients with systemic autoimmune diseases, systemic vasculitides, and organ
transplantation, and upon exposure to toxic substances such as isocyanates, trimellitic anhydrides, and certain
pesticides, recreational drugs such as crack cocaine, and medications such as certain chemotherapeutic
agents, propylthiouracil, and diphenylhydantoin. Advances in the pathogenesis of diffuse lung hemorrhage
have been hampered because of the heterogeneity of clinical findings, paucity of access to the affected tissue,
and the lack of suitable animal models. The observation that a hydrocarbon oil, 2,6,10,14-tetramethyl
pentadecane (TMPD), induces diffuse lung hemorrhage in otherwise normal animals such as C57BL/6 mice
provides an opportunity to investigate the pathogenesis of diffuse lung hemorrhage, particularly to glean into
the early pathogenetic events, since the exact timing of the inciting agent is known.
TMPD (C19H40) is an alkane present in crude oils, as a byproduct of the fractional distillation of petroleum,
and as a component of mineral oil, and in many plants and marine organisms. Humans can be exposed to
substantial amounts of hydrocarbon oils via ingestion (foods, medications), inhalation (diesel exhaust, oil mists,
aspiration of ingested oil), skin absorption (cosmetics, skin contact), or injection (accidental inoculation) over
the course of lifetime. In fact, an exposure to TMPD has been shown to cause inflammation in the lungs, liver,
and lymph nodes in humans, although it is not known whether human exposure to TMPD can cause lung
hemorrhage. A community comparison study did show that people living near an oil-field waste site with
increased levels of TMPD in house dust had an increased prevalence of immune-mediated disorders, and
increased proportions of B cells in their peripheral blood compared to the control population. The preliminary
data in this proposal shows that B cells are among the first to infiltrate the lungs after administration of TMPD,
but not of a control hydrocarbon oil in animals that are susceptible to develop diffuse lung hemorrhage.
Therefore, this proposal will investigate mechanisms of contribution of B cells in the pathogenesis of TMPD-
induced diffuse lung hemorrhage. The findings obtained will form the basis for assessing the role of B cells and
manipulating them in patients with diffuse lung hemorrhage. Studies of pathogenesis in the TMPD induced
lung hemorrhage will serve as a model for in vivo manipulation to identify potential biomarkers and targets of
treatment for diffuse lung hemorrhage, as well as to translate the murine findings onto patients with this
serious, often fatal, disorder.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ram Raj Singh其他文献
Occurrence of autoimmune diseases and relationship of autoantibody expression with HLA phenotypes in multicase rheumatoid arthritis families.
多例类风湿性关节炎家系中自身免疫性疾病的发生及自身抗体表达与 HLA 表型的关系。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:2.1
- 作者:
V. Taneja;Ram Raj Singh;Anand N. Malaviya;C. Anand;Narinder K. Mehra - 通讯作者:
Narinder K. Mehra
Ram Raj Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ram Raj Singh', 18)}}的其他基金
Role of Innate B1 B Cells in the Development of Diffuse Lung Hemorrhage
先天 B1 B 细胞在弥漫性肺出血发展中的作用
- 批准号:
9316608 - 财政年份:2016
- 资助金额:
$ 19.25万 - 项目类别:
Decidual T Cells in Immune-mediated Pregnancy Loss
蜕膜 T 细胞在免疫介导的妊娠丢失中的作用
- 批准号:
8932614 - 财政年份:2015
- 资助金额:
$ 19.25万 - 项目类别:
Decidual T Cells in Immune-mediated Pregnancy Loss
蜕膜 T 细胞在免疫介导的妊娠丢失中的作用
- 批准号:
9107907 - 财政年份:2015
- 资助金额:
$ 19.25万 - 项目类别:
Gender Bias in Lupus: Contribution of Sex Chromosomes
狼疮中的性别偏差:性染色体的贡献
- 批准号:
7903679 - 财政年份:2009
- 资助金额:
$ 19.25万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 19.25万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 19.25万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 19.25万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 19.25万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 19.25万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 19.25万 - 项目类别: